Cosmetic cross-reference

Daidzein

CAS 486-66-8

Daidzein (CAS 486-66-8) is a Phase 2 pharmaceutical compound with 9 bioactivity targets and 0 adverse event associations.

SOURCE NLM DailyMed

Label records

SOURCE EMBL-EBI ChEMBL

Bioactivity

SOURCE DrugCentral

Adverse signals

SOURCE IUPHAR/BPS

PubMed IDs

SOURCE EMBL-EBI ChEMBL B25820EEF0F0

Compound Identity

Matched identifiers and naming fields for the pharmaceutical compound record.

Primary Name

Daidzein

CAS Number

486-66-8

UNII

6287WC5J2L

InChIKey

ZQSIJRDFPHDXIC-UHFFFAOYSA-N

ChEMBL ID

CHEMBL8145

Molecule Type

Small molecule

Source Match

EMBL-EBI ChEMBL (INCHIKEY)

natural product

SOURCE EMBL-EBI ChEMBL B25820EEF0F0

Clinical Development Phase

Highest clinical development phase rendered from the matched compound identifier rows.

Phase 2

Mid-stage clinical development phase from the compound identifier source.

ChEMBL CHEMBL8145 | Small molecule

SOURCE Ingredients table / CosIng profile same-CAS cross-reference

Cross-Reference to Cosmetics

Same-CAS ingredient record found in the cosmetics vertical.

This substance also has a cosmetic safety profile →

SOURCE EMBL-EBI ChEMBL 9 bioactivity rows

Bioactivity & Target Interactions

Target-level activity records with assay counts, activity type, and measured value where present.

Target	Activity	Value	Assays	Organism
-	Potency	18282.847014925374 nM	80	-
-	IC50	34834.52392156862 nM	49	-
-	Ki	15359.9125 nM	8	-
-	MIC	50000 nM	7	-
-	MIC	352 ug.mL-1	7	-
-	AC50	12771.272 nM	5	-
-	IC50	10.897499999999999 ug.mL-1	4	-
-	GI50	159000 nM	2	-
-	Kd	5900 nM	1	-

SOURCE IUPHAR/BPS 4 interactions

IUPHAR Ligand-Target Data

Curated ligand-target interaction rows with action, affinity, and literature identifiers.

Target	Action	Affinity	PubMed
Estrogen-related receptor-α ESRRA	Agonist	-	14638870
Estrogen-related receptor-β ESRRB	Agonist	-	14638870
Estrogen-related receptor-γ ESRRG	Agonist	-	14638870
TRPC5 TRPC5	Activator	-	-

SOURCE Rendered pharma page rows FAQPage JSON-LD

Frequently Asked Questions

Short answers generated only from the same visible source-linked rows on this page.

What is Daidzein used for in pharmaceutical contexts?

Daidzein (CAS 486-66-8) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.

What are the known adverse events for Daidzein?

No adverse-event association or SIDER side-effect rows are rendered for Daidzein in this page query. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.

Is Daidzein also used in cosmetics?

Yes. The ingredients table has a same-CAS cosmetic profile for Daidzein with EU status "permitted".

What clinical phase is Daidzein in?

Daidzein is rendered with ChEMBL max phase 2.